AffiliationDivision of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, Ont., Canada. email@example.com
MetadataShow full item record
AbstractThe consequences of premature menopause are of great importance to cancer survivors. Oestrogen replacement therapy (with and without added progestins) is the most extensively researched agent for the treatment and prevention of menopausal problems. While this may be appropriate for symptom control in patients with tumours that are not hormone responsive, patients with hormone dependent tumours will require safe and effective alternative treatments for menopausal symptoms. This paper will discuss both the short-term and long-term consequences of the menopause in cancer survivors and will also offer various management strategies.
CitationManagement of the menopause in cancer survivors. 2002, 28 (6):321-33 Cancer Treat. Rev.
JournalCancer Treatment Reviews
- Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
- Authors: Mortimer JE
- Issue date: 2002 Sep
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
- Authors: Cobin RH, Goodman NF, AACE Reproductive Endocrinology Scientific Committee.
- Issue date: 2017 Jul
- Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.
- Authors: Bordeleau L, Pritchard K, Goodwin P, Loprinzi C
- Issue date: 2007 Feb
- Menopausal hormone therapy: is it OK after all? Weighing symptom relief against the risk.
- Issue date: 2016 Winter
- Oestrogen replacement in postmenopausal women.
- Authors: Sassarini J, Lumsden MA
- Issue date: 2015 Jul